Medical information through media may influence physicians ’ prescriptions of medication. The Japan Broadcasting Corporation (NHK) aired on April and May 2005, a special program called ‘Questioning Cancer Treatment in Japan’, covering oxaliplatin. We investi-gated potential impact of this program on prescriptions, utilizing a post-marketing clinical trial monitoring of all patients receiving oxaliplatin. The post-marketing clinical trial reached the target sample size of 1200 by the 4th week of May, 44 weeks sooner than anticipated. The newly registered numbers of facilities and patients exhibited a bimodal peak in April and June. The viewer rating of NHK special was 8.3%, whereas three national newspapers and one weekly magazine took up th...
Background: While disclosure of cancer is routine in the United States, it is not in Japan. The prim...
Japanese patients having terminal cancer are generally not told their true diagnosis. Japanese physi...
Cisplatin is frequently used in Japan for the treatment of advanced gastric cancer [1–3]. Docetaxel ...
Objective: Japanese weekly magazines, which have a circulation of over 2 700 000, play im-portant ro...
The aim of this nationwide survey was to investigate the use of Kampo medicine by Japanese physician...
Copyright © 2012 Toshihide Nishimura et al. This is an open access article distributed under the Cre...
This study analyzes how Japan’s two leading newspapers, Yomiuri Shimbun and Asahi Shimbun, covered a...
Background: Oxaliplatin, a platinum compound, has been commonly used around the world for treating a...
Background: Although oxaliplatin (L-OHP) combined with infusional 5-fluorouracil (5-FU) and leucovor...
Copyright © 2012 A. Ito et al. This is an open access article distributed under the Creative Commons...
Background: Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no Japanese ...
Despite high unmet medical needs, investment in rare cancer drug development has stagnated, likely b...
BackgroundOxaliplatin (OXA), a third-generation platinum derivative, has become one of the main chem...
Abstract Background Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no J...
ABSTRACTIn this study, information on injectable anticancer drug use and additional fee for enhanced...
Background: While disclosure of cancer is routine in the United States, it is not in Japan. The prim...
Japanese patients having terminal cancer are generally not told their true diagnosis. Japanese physi...
Cisplatin is frequently used in Japan for the treatment of advanced gastric cancer [1–3]. Docetaxel ...
Objective: Japanese weekly magazines, which have a circulation of over 2 700 000, play im-portant ro...
The aim of this nationwide survey was to investigate the use of Kampo medicine by Japanese physician...
Copyright © 2012 Toshihide Nishimura et al. This is an open access article distributed under the Cre...
This study analyzes how Japan’s two leading newspapers, Yomiuri Shimbun and Asahi Shimbun, covered a...
Background: Oxaliplatin, a platinum compound, has been commonly used around the world for treating a...
Background: Although oxaliplatin (L-OHP) combined with infusional 5-fluorouracil (5-FU) and leucovor...
Copyright © 2012 A. Ito et al. This is an open access article distributed under the Creative Commons...
Background: Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no Japanese ...
Despite high unmet medical needs, investment in rare cancer drug development has stagnated, likely b...
BackgroundOxaliplatin (OXA), a third-generation platinum derivative, has become one of the main chem...
Abstract Background Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no J...
ABSTRACTIn this study, information on injectable anticancer drug use and additional fee for enhanced...
Background: While disclosure of cancer is routine in the United States, it is not in Japan. The prim...
Japanese patients having terminal cancer are generally not told their true diagnosis. Japanese physi...
Cisplatin is frequently used in Japan for the treatment of advanced gastric cancer [1–3]. Docetaxel ...